giambjj
08-12-2001, 02:40 PM
The CEO of this bioteck firm from Athens,Ga was quoted in the Atlanta Journal Constituion today that they will have a marketable stem cell product to treat human CNS diseases in 2007. Also, they believe that the first therapies will not be covered by insurance, and will be too costly for the majority of those in need. BresGen has several stem cell lines that have been approved for funding by the US government.
This news is good for stock holders, but sad for those waiting for a quick cure!
JJG
This news is good for stock holders, but sad for those waiting for a quick cure!
JJG